Cancer Drug Customs Duty
- All
- News
-
Union Budget 2026 Signals Prevention-Led, Innovation-Driven Healthcare Shift, Say Industry Leaders
Union Budget 2026 places strong emphasis on prevention, biopharma innovation and mental health, with industry leaders highlighting the importance of early screening, stronger regulation and faster access to global medical innovation.
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
Union Budget 2026 Puts Healthcare Growth At Centre With Biopharma, Mental Health, Cancer Care Focus
The Union Budget presented by Finance Minister Nirmala Sitharaman in Parliament on Sunday on healthcare and pharmaceuticals pushed biopharma manufacturing, research, and skilled manpower.
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
-
Cancer Drugs To Get Cheaper In N Sitharaman's Big Budget Announcement
Finance Minister Nirmala Sitharaman announced Saturday that 36 lifesaving drugs and medicines, particularly for cancer patients and those suffering from rare diseases, will be fully exempt from basic customs duty(BCD).
-
Budget 2025: 36 Life-Saving Drugs Fully Exempted From Basic Customs Duty
Budget 2025: 36 life-saving drugs have been fully exempted from basic customs duty, Union Finance Minister Nirmala Sitharaman announced on Saturday.
-
Budget 2024: Centre To Remove Customs Duty On 3 Life-Saving Cancer Medicines
Union Finance Minister Nirmala Sitharaman proposed to completely slash the custom duties on three cancer medicines. Centre has proposed to cut the custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to zero.
-
Reconsider Move To Remove Drugs From Duty Exemption: CPI(M)
CPI(M) today asked the Centre to reconsider its decision to remove over 70 drugs including life-saving ones used for treating cancer and HIV from customs duty exemption list, saying the move will make these more expensive resulting in "severe" hardships for patients.
-
Government Reviewing Move To Withdraw Customs Duty Exemption For Drugs
Fearing a rise in prices of life-saving medicines, the government is reviewing its decision to withdraw customs duty exemption for the import of 74 drugs, including those for treating cancer, AIDS and haemophilia.
-
'Make In India' Push Fuels Price Rise Fear For 74 Vital Medicines
At least 74 drugs -- including life-saving ones used to treat cancer and HIV and haemophilia -- will see a sharp rise in prices as the government has withdrawn customs duty exemption on their imports in a move, some say, that's meant to boost the Make in India programme.
-
Duty on life-saving drugs reduced
The government has reduced basic customs duty on influenza vaccine and nine other specified life-saving drugs used for treating breast cancer, hepatitis-B, rheumatic arthritis.
-
Union Budget 2026 Signals Prevention-Led, Innovation-Driven Healthcare Shift, Say Industry Leaders
Union Budget 2026 places strong emphasis on prevention, biopharma innovation and mental health, with industry leaders highlighting the importance of early screening, stronger regulation and faster access to global medical innovation.
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
Union Budget 2026 Puts Healthcare Growth At Centre With Biopharma, Mental Health, Cancer Care Focus
The Union Budget presented by Finance Minister Nirmala Sitharaman in Parliament on Sunday on healthcare and pharmaceuticals pushed biopharma manufacturing, research, and skilled manpower.
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
-
Cancer Drugs To Get Cheaper In N Sitharaman's Big Budget Announcement
Finance Minister Nirmala Sitharaman announced Saturday that 36 lifesaving drugs and medicines, particularly for cancer patients and those suffering from rare diseases, will be fully exempt from basic customs duty(BCD).
-
Budget 2025: 36 Life-Saving Drugs Fully Exempted From Basic Customs Duty
Budget 2025: 36 life-saving drugs have been fully exempted from basic customs duty, Union Finance Minister Nirmala Sitharaman announced on Saturday.
-
Budget 2024: Centre To Remove Customs Duty On 3 Life-Saving Cancer Medicines
Union Finance Minister Nirmala Sitharaman proposed to completely slash the custom duties on three cancer medicines. Centre has proposed to cut the custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to zero.
-
Reconsider Move To Remove Drugs From Duty Exemption: CPI(M)
CPI(M) today asked the Centre to reconsider its decision to remove over 70 drugs including life-saving ones used for treating cancer and HIV from customs duty exemption list, saying the move will make these more expensive resulting in "severe" hardships for patients.
-
Government Reviewing Move To Withdraw Customs Duty Exemption For Drugs
Fearing a rise in prices of life-saving medicines, the government is reviewing its decision to withdraw customs duty exemption for the import of 74 drugs, including those for treating cancer, AIDS and haemophilia.
-
'Make In India' Push Fuels Price Rise Fear For 74 Vital Medicines
At least 74 drugs -- including life-saving ones used to treat cancer and HIV and haemophilia -- will see a sharp rise in prices as the government has withdrawn customs duty exemption on their imports in a move, some say, that's meant to boost the Make in India programme.
-
Duty on life-saving drugs reduced
The government has reduced basic customs duty on influenza vaccine and nine other specified life-saving drugs used for treating breast cancer, hepatitis-B, rheumatic arthritis.
